Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Here's a brief video on the basic premise of treating locally advanced non-small cell lung cancer.
[powerpress]
I'll plan to do others in which I'll cover more details on it. And if you've got video topics for me to cover, just offer your suggestions.
When I was a medical student, the question about lung cancer that was always asked on "the Boards" had to do with the difference between stage IIIA and stage IIIB non-small cell lung cancer (NSCLC). The reason this question was always asked is because patients with stage IIIA NSCLC might be considered for surgery, whereas patients with stage IIIB NSCLC would not be considered for surgery and instead would be treated with chemotherapy and radiation. The idea is that young doctors should be able to make that distinction and to direct patients to the appropriate specialist/treatment.
Here is the third portion of a talk I did at the Seattle-based non-profit Cancer Lifeline in May, and this section focuses on our current standards for managing unresectable locally advanced (stage III NSCLC). This covers theissues of sequential vs. concurrent chemo with radiation and the important issue of whether additional consolidation chemo after the radiation is feasible and advisable. It also covers the emerging key trials being done in this treatment setting.
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.